The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

While winter is often blamed for eczema flare-ups, summer in Tampa Bay brings its own set of skin challenges—especially for residents who live for sunshine, pool days, and ...

On top of that eczema can sometimes cause the affected areas to lighten or darken post-flare-up. For many patients these ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ...

While certain skin conditions such as acne can seem easy to diagnose from home, others can be a bit trickier, like eczema and ...

Children with cow’s milk protein allergy may have a lower incidence of allergic manifestations when their diet includes a probiotic-enhanced formula, new research shows.